$3.46 Billion is the total value of NEA Management Company, LLC's 57 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 8.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Sell | ROBINHOOD MKTS INC | $643,943,000 | -49.3% | 47,664,177 | -33.3% | 18.60% | -27.5% | |
| BHG | Sell | BRIGHT HEALTH GROUP INC | $421,149,000 | -43.9% | 218,212,126 | -0.0% | 12.16% | -19.8% |
| Buy | IONQ INC | $373,585,000 | -23.5% | 29,277,852 | +0.2% | 10.79% | +9.4% | |
| CRSP | CRISPR THERAPEUTICS AGnamen akt | $365,593,000 | +203.4% | 1,590,002 | 0.0% | 10.56% | +333.7% | |
| NET | CLOUDFLARE INC | $224,738,000 | -9.0% | 1,877,510 | 0.0% | 6.49% | +30.1% | |
| BERKSHIRE GREY INC | $110,093,000 | -47.6% | 38,226,621 | 0.0% | 3.18% | -25.2% | ||
| GLUE | MONTE ROSA THERAPEUTICS INC | $107,999,000 | -31.3% | 7,703,205 | 0.0% | 3.12% | -1.9% | |
| CTIC | CTI BIOPHARMA CORP | $99,804,000 | +463.6% | 7,140,450 | 0.0% | 2.88% | +705.3% | |
| MIRM | MIRUM PHARMACEUTICALS INC | $92,215,000 | +38.1% | 4,187,801 | 0.0% | 2.66% | +97.3% | |
| BUZZFEED INC | $72,591,000 | -11.2% | 15,333,892 | 0.0% | 2.10% | +26.9% | ||
| New | ARCELLX INC | $72,206,000 | – | 6,437,764 | +100.0% | 2.09% | – | |
| OYST | OYSTER PT PHARMA INC | $68,970,000 | -36.3% | 5,925,287 | 0.0% | 1.99% | -8.9% | |
| DM | DESKTOP METAL INC | $68,292,000 | -4.2% | 14,407,594 | 0.0% | 1.97% | +36.9% | |
| RYTM | RHYTHM PHARMACEUTICALS INC | $56,590,000 | +15.4% | 4,912,306 | 0.0% | 1.64% | +65.0% | |
| NEXTNAV INC | $55,203,000 | -23.0% | 8,189,156 | 0.0% | 1.60% | +10.0% | ||
| AUPH | Buy | AURINIA PHARMACEUTICALS INC | $49,146,000 | -30.0% | 3,969,834 | +29.3% | 1.42% | +0.1% |
| Buy | MINERVA SURGICAL INC | $40,508,000 | -21.2% | 10,001,937 | +0.0% | 1.17% | +12.6% | |
| ADAP | ADAPTIMMUNE THERAPEUTICS PLCadr | $35,190,000 | -45.1% | 17,082,611 | 0.0% | 1.02% | -21.5% | |
| COUR | COURSERA INC | $33,346,000 | -91.4% | 15,867,769 | 0.0% | 0.96% | -87.7% | |
| NKTX | NKARTA INC | $33,059,000 | -25.9% | 2,904,974 | 0.0% | 0.96% | +6.0% | |
| SVRA | SAVARA INC | $31,621,000 | +5.6% | 24,137,931 | 0.0% | 0.91% | +50.9% | |
| VRNA | VERONA PHARMA PLCads | $25,492,000 | -25.7% | 5,108,563 | 0.0% | 0.74% | +6.1% | |
| EAR | EARGO INC | $23,914,000 | +3.7% | 4,520,670 | 0.0% | 0.69% | +48.3% | |
| GERN | Buy | GERON CORP | $22,193,000 | +35.1% | 16,318,681 | +21.2% | 0.64% | +93.1% |
| AVEO | Sell | AVEO PHARMACEUTICALS INC | $22,097,000 | +19.2% | 3,952,957 | -0.0% | 0.64% | +70.1% |
| AKUS | AKOUOS INC | $20,418,000 | -44.1% | 4,298,488 | 0.0% | 0.59% | -20.1% | |
| VTGN | VISTAGEN THERAPEUTICS INC | $20,215,000 | -36.4% | 16,302,596 | 0.0% | 0.58% | -9.0% | |
| AFMD | AFFIMED NV | $19,344,000 | -20.8% | 4,426,488 | 0.0% | 0.56% | +13.2% | |
| TRVI | Sell | TREVI THERAPEUTICS INC | $17,144,000 | +270.0% | 2,798 | -100.0% | 0.50% | +426.6% |
| IVA | INVENTIVA SAads | $14,857,000 | -16.3% | 1,298,700 | 0.0% | 0.43% | +19.5% | |
| BILL | Buy | BILL COM HLDGS INC | $14,241,000 | -13.5% | 66,100 | +0.0% | 0.41% | +23.4% |
| CVRX | CVRX INC | $14,201,000 | -51.0% | 2,370,858 | 0.0% | 0.41% | -30.0% | |
| RPHM | RENEO PHARMACEUTICALS INC | $14,073,000 | -65.6% | 4,786,921 | 0.0% | 0.41% | -50.9% | |
| CSBR | CHAMPIONS ONCOLOGY INC | $13,932,000 | -2.8% | 1,713,720 | 0.0% | 0.40% | +38.6% | |
| GLBE | New | GLOBAL E ONLINE LTD | $13,264,000 | – | 436,282 | +100.0% | 0.38% | – |
| GNCA | GENOCEA BIOSCIENCES INC | $12,971,000 | +7.8% | 10,376,936 | 0.0% | 0.38% | +54.3% | |
| MILE | METROMILE INC | $12,387,000 | -39.7% | 9,384,285 | 0.0% | 0.36% | -13.7% | |
| ALLK | ALLAKOS INC | $12,339,000 | -41.8% | 2,164,704 | 0.0% | 0.36% | -16.8% | |
| STSA | SATSUMA PHARMACEUTICALS INC | $11,943,000 | -15.6% | 3,142,958 | 0.0% | 0.34% | +20.6% | |
| GLYC | GLYCOMIMETICS INC | $10,361,000 | -20.8% | 9,089,041 | 0.0% | 0.30% | +13.3% | |
| SYBX | SYNLOGIC INC | $10,150,000 | -0.8% | 4,229,410 | 0.0% | 0.29% | +41.5% | |
| INZY | INOZYME PHARMA INC | $9,997,000 | -40.0% | 2,444,379 | 0.0% | 0.29% | -14.2% | |
| BDTX | BLACK DIAMOND THERAPEUTICS INC | $9,556,000 | -48.0% | 3,449,845 | 0.0% | 0.28% | -25.8% | |
| PHAS | Sell | PHASEBIO PHARMACEUTICALS INC | $8,770,000 | -49.4% | 6,643,702 | -0.0% | 0.25% | -27.7% |
| Sell | XERIS BIOPHARMA HOLDINGS INC | $8,312,000 | -12.7% | 3,246,785 | -0.1% | 0.24% | +25.0% | |
| OBSV | OBSEVA SA | $6,926,000 | -24.1% | 4,586,563 | 0.0% | 0.20% | +8.7% | |
| IMRA | Sell | IMARA INC | $6,219,000 | -22.9% | 3,308,093 | -7.8% | 0.18% | +10.4% |
| MEIP | MEI PHARMA INC | $5,141,000 | -77.4% | 8,533,072 | 0.0% | 0.15% | -67.8% | |
| LXRX | LEXICON PHARMACEUTICALS INC | $4,979,000 | -47.0% | 2,382,286 | 0.0% | 0.14% | -24.2% | |
| MRKR | MARKER THERAPEUTICS INC | $4,714,000 | -53.7% | 10,714,285 | 0.0% | 0.14% | -34.0% | |
| AIRSPAN NETWORKS HOLDINGS INC | $4,466,000 | -23.2% | 1,534,140 | 0.0% | 0.13% | +10.3% | ||
| RGLS | Buy | REGULUS THERAPEUTICS INC | $4,306,000 | +108.6% | 14,451,147 | +124.0% | 0.12% | +195.2% |
| UP | WHEELS UP EXPERIENCE INC | $3,300,000 | -33.0% | 1,061,259 | 0.0% | 0.10% | -5.0% | |
| LUMO | Sell | LUMOS PHARMA INC | $1,575,000 | -39.7% | 167,608 | -55.5% | 0.04% | -15.1% |
| ADXN | ADDEX THERAPEUTICS LTDsponsored ads | $914,000 | +345.9% | 180,000 | 0.0% | 0.03% | +550.0% | |
| TCON | Buy | TRACON PHARMACEUTICALS INC | $912,000 | -5.0% | 346,719 | +0.0% | 0.03% | +36.8% |
| AKTX | AKARI THERAPEUTICS PLCadr | $543,000 | -19.9% | 452,167 | 0.0% | 0.02% | +14.3% | |
| TPST | Exit | TEMPEST THERAPEUTICS INC | $0 | – | -117,785 | -100.0% | -0.01% | – |
| ANNX | Exit | ANNEXON INC | $0 | – | -901,537 | -100.0% | -0.21% | – |
| CSPR | Exit | CASPER SLEEP INC | $0 | – | -6,226,130 | -100.0% | -0.84% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| GLYCOMIMETICS INC | 39 | Q3 2023 | 7.6% |
| AURINIA PHARMACEUTICALS INC | 37 | Q3 2023 | 5.0% |
| CHAMPIONS ONCOLOGY INC | 33 | Q3 2023 | 1.2% |
| LEXICON PHARMACEUTICALS INC | 32 | Q3 2023 | 2.0% |
| ADAPTIMMUNE THERAPEUTICS PLC | 31 | Q3 2023 | 9.3% |
| TREVENA INC | 31 | Q3 2021 | 3.3% |
| AKARI THERAPEUTICS PLC | 31 | Q2 2023 | 0.3% |
| ARDELYX INC | 29 | Q3 2021 | 11.9% |
| RIGEL PHARMACEUTICALS INC | 29 | Q2 2020 | 0.6% |
| EPIZYME INC | 28 | Q1 2020 | 9.6% |
View NEA Management Company, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-10 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-12 |
View NEA Management Company, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.